Nuvalent, Inc. ($NUVL)
Filing Information
| Accession Number | 0002029477-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 16, 2026 |
| Document | View SEC Filing |
Transactions
14
Total Shares
69,744
Total Value
$3,988,728.41
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | Mar 12, 2026 | Exercise/Conversion | 8,456 | $18.93 | $160,072.08 | 91,844 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Mar 12, 2026 | Exercise/Conversion | 1,754 | $27.85 | $48,848.90 | 93,598 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Mar 12, 2026 | Exercise/Conversion | 4,125 | $29.33 | $120,986.25 | 97,723 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Mar 12, 2026 | Exercise/Conversion | 2,985 | $72.35 | $215,964.75 | 100,708 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Mar 12, 2026 | Sale | 24,189 | $97.79 | $2,365,442.31 | 76,519 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Mar 12, 2026 | Sale | 5,505 | $98.44 | $541,912.20 | 71,014 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Mar 12, 2026 | Sale | 306 | $99.12 | $30,330.72 | 70,708 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Mar 13, 2026 | Sale | 804 | $97.89 | $78,703.56 | 69,904 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Mar 13, 2026 | Sale | 2,597 | $98.83 | $256,661.51 | 67,307 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Mar 13, 2026 | Sale | 1,703 | $99.71 | $169,806.13 | 65,604 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Mar 12, 2026 | Exercise/Conversion | 8,456 | $0.00 | $0.00 | 2,113 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Mar 12, 2026 | Exercise/Conversion | 1,754 | $0.00 | $0.00 | 11,402 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Mar 12, 2026 | Exercise/Conversion | 4,125 | $0.00 | $0.00 | 9,900 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Mar 12, 2026 | Exercise/Conversion | 2,985 | $0.00 | $0.00 | 21,073 | Direct | โ | View Details |